Our faculty comprises 10 schools, various centres and institutes, each with a unique purpose and focus. We are committed to making maximum impact through an ongoing pursuit of excellence and innovation.
Melbourne-based drug developer Cancer Therapeutics CRC (CTx) has received a sought-after award in recognition of its work on novel oncology drug candidates, based on early research conducted at Monash University.
Published today in the journal Science Signaling, research by Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with the Monash Institute of Pharmaceutical Sciences (MIPS), reveals how certain proteins cause the white blood cells that play a central role in inflammatory responses to behave in different ways. White blood cells are beneficial in helping to eliminate invading microorganisms or repair damaged tissue, but they can prolong the response and damage healthy tissues, leading to disease.
Associate Professor Peter Holmes, former Deputy Director of Monash Lung and Sleep, was recently awarded the prestigious Society Medal by the Thoracic Society of Australia and New Zealand at their 2017 Annual Scientific Meeting held in Canberra.